Streetbeat News

Products Services

VCEL

Vericel Corporation has received FDA approval for the arthroscopic delivery of its MACI product, enhancing knee cartilage treatment options.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:47 am

ELAB

Elevai Labs' stock is trading higher following the successful completion of a clinical study on the effectiveness of Elevai exosomes for facial appearance improvement.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:46 am

BA

GD

LMT

NOC

PPA

RTX

XAR

Defense companies like Lockheed Martin, RTX, and others are expected to see a significant increase in cash flow due to rising geopolitical tensions, with projections of $52 billion by 2026. This growth is driven by increased military spending in response to global conflicts.

Portfolio Pulse from Benzinga Neuro

August 26, 2024 | 11:43 am

RIVN

A fire at Rivian's Illinois plant damaged several vehicles but did not affect the plant itself. No injuries were reported. The plant is Rivian's only operational facility, with plans for a new plant in Georgia currently on hold.

Portfolio Pulse from Anan Ashraf

August 26, 2024 | 11:43 am

NNVC

NanoViricides, Inc. is exploring the use of its antiviral drug NV-387 for treating MPOX under the WHO MEURI protocol amid a global outbreak. NV-387 has shown promising results in safety and effectiveness in preclinical trials, potentially positioning it as a revolutionary treatment for various viral infections.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:39 am

ELAB

Elevai Labs, Inc. (NASDAQ:ELAB) has completed a clinical study on its Elevai enfinity™ skincare treatment, showing significant improvements in skin appearance. The study results, pending peer review, will be published soon.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:37 am

BGNE

BeiGene shares rose following the FDA's Fast Track Designation for BGB-16673, potentially accelerating its development and review process.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:27 am

MS

Morgan Stanley has reduced its global oil demand growth forecast for 2024 due to slower economic growth in China, increased electric vehicle adoption, and a rise in LNG-powered trucks. The bank also lowered its Brent price forecast, expecting prices to average $80 per barrel in Q4, down from $85. OPEC has also revised its global oil demand growth estimates for 2024 and 2025.

Portfolio Pulse from Lekha Gupta

August 26, 2024 | 11:17 am

BA

Elon Musk criticized Boeing's ability to dominate the space industry, comparing it to car companies' failed attempts to dominate aviation. Boeing's Starliner spacecraft faced technical issues, leading NASA to use SpaceX for astronaut return. Musk remains optimistic about Boeing's future under new CEO Kelly Ortberg.

Portfolio Pulse from Anan Ashraf

August 26, 2024 | 11:14 am

RDHL

RedHill Biopharma's drug Opaganib has received Orphan-Drug Designation from the FDA for treating neuroblastoma, a type of childhood cancer. This designation could lead to a seven-year marketing exclusivity and other benefits if approved.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:11 am